Screening and identification of peritoneal metastasis-related genes of gastric adenocarcinoma using a cDNA microarray

Genetics and Molecular Research

Volumn 11, Issue 2, 2012, Pages 1682-1689

  Bai, F H ^a,b   Wang, N J ^b   Wang, J ^a   Yang, L ^b   Zhang, F M ^a   Yin, F ^a   Liang, J ^a   Wu, K C ^a   Fan, D M ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Affiliated Hospital of Ninxia Medical College   (China)

Author keywords

cDNA microarray; Differential gene expression; Gastric cancer; Peritoneal dissemination

Indexed keywords

CALVASCULIN; COMPLEMENTARY DNA; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; CANCER CELL CULTURE; CANCER RISK; CONTROLLED STUDY; CTNNB1 GENE; DNA MICROARRAY; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SCREENING; HUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM METASTASIS; PTEN GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; S100A4 GENE; STOMACH ADENOCARCINOMA; WESTERN BLOTTING;

EID: 84930473353     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.June.25.1     Document Type: Article

References (28)

1. Arboleda MJ, Lyons JF and Kabbinavar FF (2003). Overexpression of AKT2/protein kinase Bh leads to up-regulation of h1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 63: 196-206.
2. Bai F, Liang J, Wang J, Shi Y, et al. (2007). Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. J. Mol. Med. 85: 169-180.
3. Brito M, Malta-Vacas J, Carmona B, Aires C, et al. (2005). Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility. Carcinogenesis 26: 2046-2049.
4. Cho YG, Nam SW, Kim TY, Kim YS, et al. (2003). Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 111: 539-545.
5. Choi MG, Sung CO, Noh JH, Kim KM, et al. (2010). Mucinous gastric cancer presents with more advanced tumor stage and weaker beta-catenin expression than nonmucinous cancer. Ann. Surg. Oncol. 17: 3053-3058.
6. Davidson B, Zhang Z, Kleinberg L, Li M, et al. (2006). Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma. Clin. Cancer Res. 12: 5944-5950.
7. Hippo Y, Yashiro M, Ishii M, Taniguchi H, et al. (2001). Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res. 61: 889-895.
8. Huerta S, Harris DM, Jazirehi A, Bonavida B, et al. (2003). Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int. J. Oncol. 22: 663-670.
9. Jemal A, Murray T, Ward E, Samuels A, et al. (2005). Cancer statistics, 2005. CA Cancer J. Clin. 55: 10-30.
10. Kang YH, Lee HS and Kim WH (2002). Promoter methylation and silencing of PTEN in gastric carcinoma. Lab. Invest. 82: 285-291.
11. Lazǎr D, Raica M, Sporea I, Tǎban S, et al. (2006). Tumor angiogenesis in gastric cancer. Rom. J. Morphol. Embryol. 47: 5-13.
12. Lee SS, Jeong HE, Liu KH, Ryu JY, et al. (2005). Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity. Pharmacogenet. Genomics 15: 105-113.
13. Li DW, Wu Q, Peng ZH, Yang ZR, et al. (2007). Expression and significance of Notch1 and PTEN in gastric cancer. Ai Zheng 26: 1183-1187.
14. Li J, Wu Y, Qian X and Sha B (2006). Crystal structure of yeast Sis1 peptide-binding fragment and Hsp70 Ssa1 C-terminal complex. Biochem. J. 398: 353-360.
15. Mori K, Aoyagi K, Ueda T, Danjoh I, et al. (2004). Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem. Biophys. Res. Commun. 313: 931-937.
16. Motoori M, Takemasa I, Doki Y, Saito S, et al. (2006). Prediction of peritoneal metastasis in advanced gastric cancer by gene expression profiling of the primary site. Eur. J. Cancer 42: 1897-1903.
17. Ong CK, Ng CY, Leong C, Ng CP, et al. (2004). Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J. Biol. Chem. 279: 743-754.
18. Retterspitz MF, Monig SP, Schreckenberg S, Schneider PM, et al. (2010). Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis. Anticancer Res. 30: 4635-4641.
19. Schena M, Shalon D, Davis RW and Brown PO (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470.
20. Schieren G, Rumberger B, Klein M, Kreutz C, et al. (2006). Gene profiling of polycystic kidneys. Nephrol. Dial. Transplant 21: 1816-1824.
21. Shapira M, Ben-Izhak O, Bishara B, Futerman B, et al. (2004). Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Cancer 100: 1615-1621.
22. Wang J, Wu K, Bai F, Zhai H, et al. (2006). Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer. Cancer Lett. 242: 20-27.
23. Wang YY, Ye ZY, Zhao ZS, Tao HQ, et al. (2010). High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann. Surg. Oncol. 17: 89-97.
24. Yanagihara K, Takigahira M, Tanaka H, Komatsu T, et al. (2005). Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci. 96: 323-332.
25. Yonemura Y, Endou Y, Kimura K, Fushida S, et al. (2000). Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin. Cancer Res. 6: 4234-4242.
26. Yonemura Y, Endo Y, Obata T and Sasaki T (2007). Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites. Cancer Sci. 98: 11-18.
27. Yoon CS, Hyung WJ, Lee JH, Chae YS, et al. (2008). Expression of S100A4, E-cadherin, alpha-and beta-catenin in gastric adenocarcinoma. Hepatogastroenterology 55: 1916-1920.
28. Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, et al. (2006). Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer. Hepatogastroenterology 53: 964-967.